TRCT
BRNS

Tower Research Capital (TRC)’s Barinthus Biotherapeutics BRNS Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$309 – 5931
2023
Q3 		$309 Sell
100
-22
-18% -$68 ﹤0.01% 5615
2023
Q2 		$251 Buy
+122
New +$251 ﹤0.01% 5694